FR 2021-03399

Overview

Title

Foreign-Trade Zone (FTZ) 266-Dane County, Wisconsin; Authorization of Production Activity; Coating Place, Inc. (Pharmaceuticals); Verona, Wisconsin

Agencies

ELI5 AI

A company called Coating Place, Inc. in Wisconsin asked for permission to make medicine in a special business area. Some people checked and said it’s okay, so now they can go ahead and do it.

Summary AI

Coating Place, Inc. applied to the Foreign-Trade Zones Board to conduct production activities at its plant in Verona, Wisconsin, part of FTZ 266. The request was processed following FTZ Board regulations, and a notice was published in the Federal Register for public comments. On February 16, 2021, the FTZ Board decided that the proposed production activities did not require further review. Consequently, the production activities were authorized, adhering to the FTZ Act and the board's regulations.

Type: Notice
Citation: 86 FR 10243
Document #: 2021-03399
Date:
Volume: 86
Pages: 10243-10244

AnalysisAI

This Federal Register notice outlines a significant development for Coating Place, Inc., located in Verona, Wisconsin. The company sought permission from the Foreign-Trade Zones (FTZ) Board to conduct production activities within the Foreign-Trade Zone 266. After reviewing the proposal under its regulations, the FTZ Board approved the requested activities on February 16, 2021, without the need for additional review.

General Summary

The document describes a procedural step taken by Coating Place, Inc. to enhance its operations through the FTZ program, which is designed to facilitate and encourage foreign commerce. The facility in question is part of a foreign trade zone in Dane County, Wisconsin. The document records the successful approval of production activities under specific regulations, marking an important step for the company in utilizing the benefits provided by the FTZ program.

Significant Issues and Concerns

There are a few notable issues within the document:

  • Lack of Detail on Pharmaceuticals: The document does not specify which pharmaceuticals will be produced, which limits the understanding of the potential scale and impact of the production activities.

  • Abstract and Purpose Clarity: An abstract at the beginning is missing. This absence might make it challenging for readers to grasp the essential aspects of the notice quickly. Additionally, the reference to 'print page 10244' lacks context, which might confuse readers regarding its relevance.

  • Economic Impact: There is no discussion of the economic impact or potential benefits that the production activities might offer, such as job creation or economic growth in the Verona area. This information would be valuable for stakeholders and local communities.

Impact on the Public and Specific Stakeholders

Broad Public Impact

For the general public, especially those interested in local economic developments, this document signifies a potential boost to the economy of Verona and surrounding areas. FTZs often contribute to increased economic activity, as they make importing raw materials and exporting finished goods more efficient and cost-effective.

Impact on Specific Stakeholders

For specific stakeholders, like local businesses and suppliers, the authorization of production activities at Coating Place, Inc. could mean more opportunities for collaboration and trade, possibly spurring local growth. Furthermore, employees and job seekers in the area might find increased employment opportunities and economic stability.

Conversely, without detailed information on the types of pharmaceuticals or the scale of operations, concerns could arise about environmental impacts or changes in traffic patterns due to increased industrial activity. Therefore, more detailed disclosures in future communications would benefit both the company and the community by addressing these potential concerns proactively.

Overall, while the document's approval of production activities is a procedural success for Coating Place, Inc., increased transparency and details about the nature of the operations and their expected impact would serve the public and stakeholders more effectively.

Issues

  • • The document lacks an abstract in the metadata, which could provide a brief summary of the notice.

  • • The document does not specify the type of pharmaceuticals involved in the production activity, which could provide more clarity.

  • • There is no information on the potential impact or economic benefit of the production activity, which could be relevant to stakeholders.

  • • The section referencing 'print page 10244' is unclear in its purpose without additional context.

Statistics

Size

Pages: 2
Words: 182
Sentences: 7
Entities: 25

Language

Nouns: 58
Verbs: 12
Adjectives: 3
Adverbs: 0
Numbers: 22

Complexity

Average Token Length:
4.58
Average Sentence Length:
26.00
Token Entropy:
4.36
Readability (ARI):
16.34

Reading Time

less than a minute